NOI Life Technologies Reagents

This Notice of Intent to award a sole source firm fixed price purchase order is provided by the Centers for Disease Control and Prevention (CDC), Office of Acquisition Services (OAS), on behalf of the Global Health Center (GHC), Division for Global HIV & Tuberculosis (DGHT), International Laboratory Branch (ILB). ILB has a requirement for the following:

The following items and corresponding quantities are required: HIV-1 Genotyping Kit with Integrase (v3), 22 each AmpliTaq Gold DNA Polymerase LD 250 units, 10 each SuperScript III One-Step RT-PCR System, 10 each Invitrogen dNTP Mix (10 mM each), 1 each BigDye XTerminator Purification Kit - 50ml, 1 each Cathode Buffer Container (CBC) 3500 Series, 3 each Anode Buffer Container (ABC) 3500 Series, 3 each Sequencing Standard v3.1 3500 Series, 1 each Conditioning Reagent 3500 Series, 1 each POP-7 Polymer for 3500/3500xL, 3 each POP-7 Polymer for 3730 28ml, 2 each 3730 DNA Analyzer Capillary Array 96 capillaries 50cm, 1 each MicroAmp Optical 8-Tube Strip w/Attached Caps, 2 each MicroAmp TriFlex 32-Well PCR Reaction Plate, 1 each MicroAmp Optical 8-Tube Strip, 2 each MicroAmp Clear Adhesive Film, 3 each MicroAmp Optical 8-Cap Strip, 3 each E-Gel 96 Agarose Gels with SYBR Safe DNA Gel Stain 2%, 1 each E-Gel 48 Agarose Gels with SYBR Safe DNA Gel Stain 2%, 1 each E-Gel EX Double Comb Agarose Gels 2%, 2 each FastRuler Middle Range DNA Ladder, 4 each ABI Nuclease Free Water 10 x 50ml, 1 each Quant-iT 1X dsDNA HS Assay 1000 preps, 2 each Life Technologies is the only company licensed to manufacture these items. The intended recipient of this purchase order is:

Life Technologies Cororation located at 3175 Staley Road, Grand Island, New York 14072. This order is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). Interested persons may identify their interest and capability by responding to this notice. This notice of intent is not a request for competitive quotations; however, all quotations/responses received by July 29, 2024 by 11:00AM EDT will be considered by the government.

A determination by the government not to compete this proposed purchase order based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Responses should be emailed to Abbie Jemmott, Contracting Officer at ajemmott@cdc.gov No telephonic quotes will be accepted.